Epilepsy—Definition, Classification, Pathophysiology, and Epidemiology

Abstract

Seizures affect the lives of 10% of the global population and result in epilepsy in 1 to 2% of people around the world. Current knowledge about etiology, diagnosis, and treatments for epilepsy is constantly evolving. As more is learned, appropriate and updated definitions and classification systems for seizures and epilepsy are of the utmost importance. Without proper definitions and classification, many individuals will be improperly diagnosed and incorrectly treated. It is also essential for research purposes to have proper definitions, so that appropriate populations can be identified and studied. Imprecise definitions, failure to use accepted terminology, or inappropriate use of terminology hamper our ability to study and advance the field of epilepsy. This article begins by discussing the pathophysiology and epidemiology of epilepsy, and then covers the accepted contemporary definitions and classifications of seizures and epilepsies.

Keywords

definition - classification - pathophysiology - epidemiology - epilepsy

Publikationsverlauf

Artikel online veröffentlicht:
05. November 2020

• References

• 1 Aaberg KM, Surén P, Søraas CL. et al. Seizures, syndromes, and etiologies in childhood epilepsy: The International League Against Epilepsy 1981, 1989, and 2017 classifications used in a population-based cohort. Epilepsia 2017; 58 (11) 1880-1891
• 2 Bosak M, Słowik A, Kacorzyk R, Turaj W. Implementation of the new ILAE classification of epilepsies into clinical practice - a cohort study. Epilepsy Behav 2019; 96: 28-32
• 3 Liu S, Yu W, Lü Y. The causes of new-onset epilepsy and seizures in the elderly. Neuropsychiatr Dis Treat 2016; 12: 1425-1434
• 4 Cloyd J, Hauser W, Towne A. et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006; 68 (Suppl. 01) S39-S48
• 5 Tanaka A, Akamatsu N, Shouzaki T. et al. Clinical characteristics and treatment responses in new-onset epilepsy in the elderly. Seizure 2013; 22 (09) 772-775
• 6 WHO. Epilepsy: A public Health Initiative. Geneva: World Health Organization; 2019
• 7 Beghi E, Giussani G, Nichols E. GBD 2016 Epilepsy Collaborators. et al; Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18 (04) 357-375
• 8 Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010; 51 (05) 883-890
• 9 Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34 (03) 453-468
• 10 Neligan A, Hauser WA, Sander JW. Chapter 6: The epidemiology of the epilepsies. In: Stefan H, Theodore WH. eds. Handbook of Clinical Neurology, Vol. 107. Amsterdam: Elsevier; 2012: 113-133
• 11 Fisher RS, van Emde Boas W, Blume W. et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46 (04) 470-472
• 12 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55 (04) 475-482
• 13 Hauser WA, Anderson VE, Loewenson RB, McRoberts SM. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982; 307 (09) 522-528
• 14 Beretta S, Carone D, Zanchi C. PRO-LONG Study Group. et al; Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study. Epilepsia 2017; 58 (09) 1518-1523
• 15 Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998; 338 (07) 429-434
• 16 Fisher RS, Cross JH, D'Souza C. et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia 2017; 58 (04) 531-542
• 17 Scheffer IE, Berkovic S, Capovilla G. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 512-521
• 18 Lapalme-Remis S, Cascino GD. Imaging for adults with seizures and epilepsy. Continuum (Minneap Minn) 2016; 22 (Suppl. 05) Neuroimaging 1451-1479
• 19 Hildebrand MS, Dahl HH, Damiano JA, Smith RJ, Scheffer IE, Berkovic SF. Recent advances in the molecular genetics of epilepsy. J Med Genet 2013; 50 (05) 271-279
• 20 Vezzani A, Fujinami RS, White HS. et al. Infections, inflammation and epilepsy. Acta Neuropathol 2016; 131 (02) 211-234
• 21 Parikh S, Nordi Jr DR, De Vivo DC. Chapter 31: Epilepsy in the setting of inherited metabolic and mitochondrial disorders. In: Wyllie E. ed. Wyllie's Treatment of Epilepsy: Principles and Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2015: 388-407
• 22 Toledano M, Pittock SJ. Autoimmune epilepsy. Semin Neurol 2015; 35 (03) 245-258
• 23 de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH. et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA_BR encephalitis. Neurology 2019; 92 (19) e2185-e2196